The top 10 biopharma stock gainers and losers for the week.

For the second time, the biopharma industry’s largest event will be held virtually as BIO Digital 2021, with pandemic preparedness and infectious diseases a running theme throughout many of the scheduled sessions.

A quick look back at top stories.

Biopharma money raised to-date and by month in 2021, including public, private and other financings.

The top 10 biopharma stock gainers and losers for the week.

Although 2020 is the highest money-making year on record for the biopharma industry, a direct comparison of the first five months indicates that the amount raised so far in 2021 is 22% ahead of last year, while the number of financings climbed 26%.